-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bepirovirsen Sodium in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bepirovirsen Sodium in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bepirovirsen Sodium in Hepatitis B Drug Details: IONIS-HBVRx (ISIS-HBVRx, ISIS-GSK3Rx)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avicursen in Duchenne Muscular Dystrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avicursen in Duchenne Muscular Dystrophy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avicursen in Duchenne Muscular Dystrophy Drug Details: ATL-1102, (TV-1102, ISIS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATL-1102 in Duchenne Muscular Dystrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATL-1102 in Duchenne Muscular Dystrophy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATL-1102 in Duchenne Muscular Dystrophy Drug Details: ATL-1102, (TV-1102, ISIS...
-
Product Insights
Isis River Solar PV Park
Isis River Solar PV Park is a solar PV project located in Queensland, Australia. The project is owned by Venn Artibir Group Pty Ltd and is developed by OX2 Australia Pty Ltd; Venn Artibir Group Pty Ltd. The project is at the permitting stage. Empower your strategies with our Isis River Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bepirovirsen Sodium in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bepirovirsen Sodium in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bepirovirsen sodium in Hepatitis B Drug Details: IONIS-HBVRx (ISIS-HBVRx, ISIS-GSK3Rx)...
-
Product Insights
Childers Biomass Power Plant II
Childers Biomass Power Plant II is a biopower project located in Queensland, Australia. The project is owned by Isis Central Sugar Mill Co Ltd and was developed by i.power solutions. The project came online in 2006. Empower your strategies with our Childers Biomass Power Plant II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Hematological Disorders Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hematological Disorders Pipeline Market Report Overview The hematological disorders pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Hemostasis Tests ·       Coagulation Analyzers ·       Special Coagulation Tests ·       Hematology Tests ·       General Coagulation Tests Key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volanesorsen Sodium in Hypertriglyceridemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volanesorsen Sodium in Hypertriglyceridemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volanesorsen Sodium in Hypertriglyceridemia Drug Details: Volanesorsen sodium (Waylivra) is an antisense...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATL-1102 in Duchenne Muscular Dystrophy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ATL-1102 in Duchenne Muscular Dystrophy Drug Details: ATL-1102, (TV-1102, ISIS 107248) is under development for...